MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 91 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $652 | +2.4% | 2,329 | -2.3% | 0.00% | 0.0% |
Q1 2024 | $637 | -55.3% | 2,384 | -61.3% | 0.00% | -66.7% |
Q4 2023 | $1,425 | +39.2% | 6,157 | -12.2% | 0.01% | +20.0% |
Q3 2023 | $1,024 | -37.3% | 7,014 | -0.8% | 0.01% | -28.6% |
Q2 2023 | $1,633 | +1.8% | 7,068 | +6.8% | 0.01% | -12.5% |
Q1 2023 | $1,604 | -56.0% | 6,620 | -47.3% | 0.01% | -57.9% |
Q4 2022 | $3,646 | -99.3% | 12,560 | +60.0% | 0.02% | +533.3% |
Q3 2022 | $510,000 | -8.1% | 7,850 | +1.3% | 0.00% | 0.0% |
Q2 2022 | $555,000 | -32.2% | 7,750 | -7.2% | 0.00% | -25.0% |
Q1 2022 | $819,000 | +31.5% | 8,350 | +13.6% | 0.00% | +33.3% |
Q4 2021 | $623,000 | -6.5% | 7,350 | -12.0% | 0.00% | 0.0% |
Q3 2021 | $666,000 | -18.1% | 8,350 | 0.0% | 0.00% | -25.0% |
Q2 2021 | $813,000 | -59.3% | 8,350 | -51.1% | 0.00% | -63.6% |
Q1 2021 | $1,996,000 | +11.8% | 17,060 | +6.2% | 0.01% | +10.0% |
Q4 2020 | $1,785,000 | -4.0% | 16,060 | +2.6% | 0.01% | -23.1% |
Q3 2020 | $1,859,000 | +5.5% | 15,660 | +0.6% | 0.01% | 0.0% |
Q2 2020 | $1,762,000 | +77.6% | 15,560 | +4.7% | 0.01% | +30.0% |
Q1 2020 | $992,000 | -26.5% | 14,860 | +0.3% | 0.01% | 0.0% |
Q4 2019 | $1,349,000 | +7.1% | 14,810 | +1.4% | 0.01% | -9.1% |
Q3 2019 | $1,259,000 | -18.3% | 14,600 | -0.7% | 0.01% | -21.4% |
Q2 2019 | $1,541,000 | -14.6% | 14,700 | +2.1% | 0.01% | -17.6% |
Q1 2019 | $1,804,000 | +26.1% | 14,400 | +13.4% | 0.02% | +6.2% |
Q4 2018 | $1,431,000 | +234.3% | 12,698 | +535.5% | 0.02% | +300.0% |
Q3 2018 | $428,000 | -49.1% | 1,998 | -33.6% | 0.00% | -55.6% |
Q2 2018 | $841,000 | -35.0% | 3,007 | -72.9% | 0.01% | -40.0% |
Q1 2018 | $1,294,000 | +60.9% | 11,082 | +26.6% | 0.02% | +66.7% |
Q4 2017 | $804,000 | +127.8% | 8,757 | +11.5% | 0.01% | +80.0% |
Q3 2017 | $353,000 | – | 7,857 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |